SCOTUS Mail-Order Abortion Ruling Endangers Women and Babies
Source: Jordan Boyd. "Women, Babies At Risk After SCOTUS Allows Mail-Order Abortion." May 15, 2026. thefederalist.com
The Gist
The author argues that the Supreme Court made a dangerous mistake by letting abortion pill companies continue mailing drugs to women without requiring doctor visits. She claims this puts women at serious medical risk and prioritizes company profits over safety.
Conclusion
The Supreme Court's decision to allow continued mail-order mifepristone distribution endangers women and babies by permitting unsafe abortion practices without proper medical oversight
Premises
- Mifepristone has serious side effects including bleeding, breathing trouble, and pain, with over 10% of women experiencing complications like hemorrhage or infection
- Mail-order distribution eliminates required in-person medical care before and after obtaining abortion pills, removing crucial safety protections
- Without in-person doctor visits, women cannot accurately determine gestational age, leading to dangerous use beyond the recommended 10-week limit
- The Supreme Court prioritized pharmaceutical companies' financial interests over women's safety by granting emergency relief based on 'substantial financial interest'
- Mail-order mifepristone distribution violates the Comstock Act and undermines state sovereignty established in Dobbs v. Jackson
- Real-world cases like plaintiff Rosalie Markezich demonstrate the dangerous consequences of abortion pill poisonings and coerced abortions
Assumptions
- In-person medical supervision significantly reduces abortion-related complications
- State regulations on abortion should take precedence over federal drug distribution policies
- Pharmaceutical company profits should not override women's safety concerns
- The cited complication rates and case studies are representative of broader risks